Skip to main content
. 2022 Aug 16;5(3):372–387. doi: 10.3138/canlivj-2021-0038

Supplemental Table 3:

Combined ALP, total bilirubin, and platelet

All patients (N = 1036) Previously on UDCA (n = 43) Currently on UDCA (n = 925) Never on UDCA (n = 68)
ALP <200 IU/L + total bilirubin ≤21 µmol/L + platelet <150 x 103, no. (%) 115 (11.1) 9 (20.9) 98 (10.6) 8 (11.8)

UDCA = Ursodeoxycholic acid; ALP = Alkaline phosphatase